Sox12 Is a Cancer Stem-Like Cell Marker in Hepatocellular Carcinoma |
Zou, Song
(Department of Interventional Oncology, the People's Hospital of Ganzhou)
Wang, Chen (Department of Oncology, the People's Hospital of Ganzhou) Liu, Jiansheng (Department of Oncology, the People's Hospital of Ganzhou) Wang, Qun (Department of Oncology, the Affiliated Hospital of Guilin Medical University) Zhang, Dongdong (Department of Oncology, the Affiliated Hospital of Guilin Medical University) Zhu, Shengnan (Department of Oncology, the Affiliated Hospital of Guilin Medical University) Xu, Shengyuan (Department of Oncology, the Affiliated Hospital of Guilin Medical University) Kang, Mafei (Department of Oncology, the Affiliated Hospital of Guilin Medical University) He, Shaozhong (Department of Oncology, the Affiliated Hospital of Guilin Medical University) |
1 | Hess, D.A., Craft, T.P., Wirthlin, L., Hohm, S., Zhou, P., Eades, W.C., Creer, M.H., Sands, M.S., and Nolta, J.A. (2008). Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity. Stem Cells 26, 611-620. DOI |
2 | Hoser, M., Potzner, M.R., Koch, J.M., Bosl, M.R., Wegner, M., and Sock, E. (2008). Sox12 deletion in the mouse reveals nonreciprocal redundancy with the related Sox4 and Sox11 transcription factors. Mol. Cell Biol. 28, 4675-4687. DOI |
3 | Houghton, B.C., Booth, C., and Thrasher, A.J. (2015). Lentivirus technologies for modulation of the immune system. Curr. Opin. Pharmacol. 24, 119-127. DOI |
4 | Huang, R., and Rofstad, E.K. (2017). Cancer stem cells (CSCs), cervical CSCs and targeted therapies. Oncotarget 8, 35351-35367. |
5 | Huang, W., Chen, Z., Shang, X., Tian, D., Wang, D., Wu, K., Fan, D., and Xia, L. (2015). Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1. Hepatology 61, 1920-1933. DOI |
6 | Ikeda, M., Shimizu, S., Sato, T., Morimoto, M., Kojima, Y., Inaba, Y., Hagihara, A., Kudo, M., Nakamori, S., Kaneko, S., et al. (2016). Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial. Ann. Oncol. 27, 2090-2096. DOI |
7 | Iqbal, W., Alkarim, S., AlHejin, A., Mukhtar, H., and Saini, K.S. (2016). Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis. Oncotarget 7, 76337-76353. |
8 | Jiang, T., Guan, L.Y., Ye, Y.S., Liu, H.Y., and Li, R. (2017). MiR-874 inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting SOX12. Am. J. Cancer Res. 7, 1310-1321. |
9 | Nagata, T., Sakakura, C., Komiyama, S., Miyashita, A., Nishio, M., Murayama, Y., Komatsu, S., Shiozaki, A., Kuriu, Y., Ikoma, H., et al. (2011). Expression of cancer stem cell markers CD133 and CD44 in locoregional recurrence of rectal cancer. Anticancer Res. 31, 495-500. |
10 | Nakata, S., Phillips, E., and Goidts, V. (2014). Emerging role for leucine-rich repeat-containing G-protein-coupled receptors LGR5 and LGR4 in cancer stem cells. Cancer Manag. Res. 6, 171-180. |
11 | Llovet, J.M., and Bruix, J. (2008). Novel advancements in the management of hepatocellular carcinoma in 2008. J. Hepatol. 48 Suppl 1, S20-37. |
12 | Ma, I., and Allan, A.L. (2011). The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev. 7, 292-306. DOI |
13 | Ma, S., Chan, K.W., Lee, T.K., Tang, K.H., Wo, J.Y., Zheng, B.J., and Guan, X.Y. (2008). Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 6, 1146-1153. DOI |
14 | Magni, M., Shammah, S., Schiro, R., Mellado, W., Dalla-Favera, R., and Gianni, A.M. (1996). Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood 87, 1097-1103. |
15 | Matsuo, N., Shiraha, H., Fujikawa, T., Takaoka, N., Ueda, N., Tanaka, S., Nishina, S., Nakanishi, Y., Uemura, M., Takaki, A., et al. (2009). Twist expression promotes migration and invasion in hepatocellular carcinoma. BMC Cancer 9, 240. DOI |
16 | Ray, P.E., Al-Attar, A., Liu, X.H., Das, J.R., Tassi, E. and Wellstein, A. (2014) Expression of a Secreted Fibroblast Growth Factor Binding Protein-1 (FGFBP1) in Angioproliferative Kaposi Sarcoma. J. AIDS Clin. Res. 5. |
17 | Ottaiano, A. (2010). Finding markers for cancer stem cells in renal cell carcinoma: looking beyond CD133. Cell Cycle 9, 4431. DOI |
18 | Perez-Losada, J., and Balmain, A. (2003) Stem-cell hierarchy in skin cancer. Nat. Rev. Cancer 3, 434-443. DOI |
19 | Petersson, M. and Niemann, C. (2012) Stem cell dynamics and heterogeneity: implications for epidermal regeneration and skin cancer. Curr. Med. Chem. 19, 5984-5992. DOI |
20 | Shi, C., Tian, R., Wang, M., Wang, X., Jiang, J., Zhang, Z., Li, X., He, Z., Gong, W., and Qin, R. (2010) CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. Cancer Biol. Ther. 10, 1182-1190. DOI |
21 | McCarron, A., Donnelley, M., McIntyre, C., and Parsons, D. (2016). Challenges of up-scaling lentivirus production and processing. J. Biotechnol. 240, 23-30. DOI |
22 | Silva, I.A., Bai, S., McLean, K., Yang, K., Griffith, K., Thomas, D., Ginestier, C., Johnston, C., Kueck, A., Reynolds, R.K., et al. (2011) Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res. 71, 3991-4001. DOI |
23 | Yang, M.H., Chen, C.L., Chau, G.Y., Chiou, S.H., Su, C.W., Chou, T.Y., Peng, W.L., and Wu, J.C. (2009). Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 50, 1464-1474. DOI |
24 | Singh, S.R. (2012). Stem cell niche in tissue homeostasis, aging and cancer. Curr. Med. Chem. 19, 5965-5974. DOI |
25 | Singh, S.K., Clarke, I.D., Terasaki, M., Bonn, V.E., Hawkins, C., Squire, J., and Dirks, P.B. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828. |
26 | Sun, B., Zhang, D., Zhao, N., and Zhao, X. (2017). Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors. Oncotarget 8, 30502-30510. |
27 | Verslype, C., Van Cutsem, E., Dicato, M., Arber, N., Berlin, J.D., Cunningham, D., De Gramont, A., Diaz-Rubio, E., Ducreux, M., Gruenberger, T., et al. (2009). The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Ann. Oncol. 20 Suppl 7, vii1-vii6. |
28 | Yan, Y., Zuo, X. and Wei, D. (2015). Concise review: emerging Role of CD44 in cancer stem cells: a promising biomarker and therapeutic target. Stem Cells Transl. Med. 4, 1033-1043. DOI |
29 | Yang, Z., Yang, Z., Zou, Q., Yuan, Y., Li, J., Li, D., Liang, L., Zeng, G., and Chen, S. (2014). A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder. Int. J. Clin. Oncol. 19, 325-335. DOI |
30 | Zhang, H., and Li, S.Y. (2010). Research progression of CD133 as a marker of cancer stem cells. Chinese J. Cancer 29, 243-247. DOI |
31 | Chiba, T., Iwama, A. and Yokosuka, O. (2016). Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology. Hepatol Res 46, 50-57. DOI |
32 | Zhang, C.H., Xu, G.L., Jia, W.D., Li, J.S., Ma, J.L., Ren, W.H., Ge, Y.S., Yu, J.H., Liu, W.B., and Wang, W. (2012). Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance. J. Surg. Res. 174, 120-129. DOI |
33 | Zhang, C., Guo, F., Xu, G., Ma, J., and Shao, F. (2015). STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Oncol. Rep. 33, 1872-1882. DOI |
34 | Zhu, H.Y., Bai, W.D., Liu, J.Q., Zheng, Z., Guan, H., Zhou, Q., Su, L.L., Xie, S.T., Wang, Y.C., Li, J., et al. (2016) Up-regulation of FGFBP1 signaling contributes to miR-146a-induced angiogenesis in human umbilical vein endothelial cells. Sci. Rep. 6, 25272. DOI |
35 | Armstrong, L., Stojkovic, M., Dimmick, I., Ahmad, S., Stojkovic, P., Hole, N., and Lako, M. (2004). Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells 22, 1142-1151. DOI |
36 | Brower, V. (2016). Sorafenib plus cisplatin for hepatocellular carcinoma. Lancet Oncol 17, e424. DOI |
37 | Cockrell, A.S., and Kafri, T. (2007). Gene delivery by lentivirus vectors. Mol. Biotechnol. 36, 184-204. DOI |
38 | Fang, D.D., Kim, Y.J., Lee, C.N., Aggarwal, S., McKinnon, K., Mesmer, D., Norton, J., Birse, C.E., He, T., Ruben, S.M., et al. (2010). Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br. J. Cancer 102, 1265-1275. DOI |
39 | Duester, G. (2000). Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur. J. Biochem. 267, 4315-4324. DOI |
40 | Dy, P., Penzo-Mendez, A., Wang, H., Pedraza, C.E., Macklin, W.B., and Lefebvre, V. (2008) The three SoxC proteins--Sox4, Sox11 and Sox12--exhibit overlapping expression patterns and molecular properties. Nucleic Acids Res 36, 3101-3117. DOI |
41 | Hess, D.A., Meyerrose, T.E., Wirthlin, L., Craft, T.P., Herrbrich, P.E., Creer, M.H., and Nolta, J.A. (2004). Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104, 1648-1655. DOI |
42 | Hess, D.A., Wirthlin, L., Craft, T.P., Herrbrich, P.E., Hohm, S.A., Lahey, R., Eades, W.C., Creer, M.H., and Nolta, J.A. (2006). Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 107, 2162-2169. DOI |